Table of Content
Table of Content
1 Antiandrogen Monotherapy Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Antiandrogen Monotherapy
1.3 Antiandrogen Monotherapy Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Antiandrogen Monotherapy Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Antiandrogen Monotherapy
1.4.2 Applications of Antiandrogen Monotherapy
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Antiandrogen Monotherapy Industry Trends
1.5.2 Antiandrogen Monotherapy Drivers
1.5.3 Antiandrogen Monotherapy Market Challenges
1.5.4 Antiandrogen Monotherapy Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Antiandrogen Monotherapy Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Antiandrogen Monotherapy Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Antiandrogen Monotherapy Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Antiandrogen Monotherapy
2.2.1 Major Players Manufacturing Base of Antiandrogen Monotherapy in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Antiandrogen Monotherapy Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Antiandrogen Monotherapy
2.3.3 Labor Cost of Antiandrogen Monotherapy
2.4 Market Channel Analysis of Antiandrogen Monotherapy
2.5 Major Down Stream Customers by Application
3 Global Antiandrogen Monotherapy Market, by Type
3.1 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2018-2021)
3.2 Global Antiandrogen Monotherapy Production and Market Share by Type (2018-2021)
3.3 Global Antiandrogen Monotherapy Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Antiandrogen Monotherapy Revenue and Growth Rate of Steroidal
3.3.2 Global Antiandrogen Monotherapy Revenue and Growth Rate of Nonsteroidal
3.4 Global Antiandrogen Monotherapy Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Antiandrogen Monotherapy Market, by Application
4.1 Downstream Market Overview
4.2 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2018-2021)
4.3 Global Antiandrogen Monotherapy Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Antiandrogen Monotherapy Consumption and Growth Rate of Prostate Cancer (2018-2021)
4.3.2 Global Antiandrogen Monotherapy Consumption and Growth Rate of Benign Prostatic Hyperplasia (2018-2021)
4.3.3 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hirsutism (2018-2021)
4.3.4 Global Antiandrogen Monotherapy Consumption and Growth Rate of Hyperandrogenism (2018-2021)
4.3.5 Global Antiandrogen Monotherapy Consumption and Growth Rate of Others (2018-2021)
5 Global Antiandrogen Monotherapy Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Antiandrogen Monotherapy Revenue and Market Share by Region (2018-2021)
5.2 Global Antiandrogen Monotherapy Consumption and Market Share by Region (2018-2021)
5.3 Global Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Antiandrogen Monotherapy Market Under COVID-19
5.4.2 North America Antiandrogen Monotherapy SWOT Analysis
5.5 Europe Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Antiandrogen Monotherapy Market Under COVID-19
5.5.2 Europe Antiandrogen Monotherapy SWOT Analysis
5.6 China Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Antiandrogen Monotherapy Market Under COVID-19
5.6.2 China Antiandrogen Monotherapy SWOT Analysis
5.7 Japan Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Antiandrogen Monotherapy Market Under COVID-19
5.7.2 Japan Antiandrogen Monotherapy SWOT Analysis
5.8 Middle East and Africa Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Antiandrogen Monotherapy Market Under COVID-19
5.8.2 Middle East and Africa Antiandrogen Monotherapy SWOT Analysis
5.9 India Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Antiandrogen Monotherapy Market Under COVID-19
5.9.2 India Antiandrogen Monotherapy SWOT Analysis
5.10 South America Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Antiandrogen Monotherapy Market Under COVID-19
5.10.2 South America Antiandrogen Monotherapy SWOT Analysis
5.11 South Korea Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Antiandrogen Monotherapy Market Under COVID-19
5.11.2 South Korea Antiandrogen Monotherapy SWOT Analysis
5.12 Southeast Asia Antiandrogen Monotherapy Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Antiandrogen Monotherapy Market Under COVID-19
5.12.2 Southeast Asia Antiandrogen Monotherapy SWOT Analysis
6 Global Antiandrogen Monotherapy Production by Top Regions (2018-2021)
6.1 Global Antiandrogen Monotherapy Production by Top Regions (2018-2021)
6.2 North America Antiandrogen Monotherapy Production and Growth Rate
6.3 Europe Antiandrogen Monotherapy Production and Growth Rate
6.4 China Antiandrogen Monotherapy Production and Growth Rate
6.5 Japan Antiandrogen Monotherapy Production and Growth Rate
6.6 India Antiandrogen Monotherapy Production and Growth Rate
7 Global Antiandrogen Monotherapy Consumption by Regions (2018-2021)
7.1 Global Antiandrogen Monotherapy Consumption by Regions (2018-2021)
7.2 North America Antiandrogen Monotherapy Consumption and Growth Rate
7.3 Europe Antiandrogen Monotherapy Consumption and Growth Rate
7.4 China Antiandrogen Monotherapy Consumption and Growth Rate
7.5 Japan Antiandrogen Monotherapy Consumption and Growth Rate
7.6 Middle East & Africa Antiandrogen Monotherapy Consumption and Growth Rate
7.7 India Antiandrogen Monotherapy Consumption and Growth Rate
7.8 South America Antiandrogen Monotherapy Consumption and Growth Rate
7.9 South Korea Antiandrogen Monotherapy Consumption and Growth Rate
7.10 Southeast Asia Antiandrogen Monotherapy Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Progenics Pharmaceuticals, Inc. Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.2.3 Progenics Pharmaceuticals, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 GlaxoSmithKline Plc Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.3.3 GlaxoSmithKline Plc Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Astellas Pharma Inc. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.4.3 Astellas Pharma Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 ALZA Corporation Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.5.3 ALZA Corporation Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Sanofi SA Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.6.3 Sanofi SA Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 OSI Pharmaceuticals, Inc. Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.7.3 OSI Pharmaceuticals, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Amgen Inc Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.8.3 Amgen Inc Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Abbott Laboratories Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.9.3 Abbott Laboratories Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 F. Hoffmann-La Roche Ltd. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.10.3 F. Hoffmann-La Roche Ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Pfizer Inc. Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.11.3 Pfizer Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 ANI Pharmaceuticals, Inc. Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.12.3 ANI Pharmaceuticals, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 AstraZeneca Plc Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.13.3 AstraZeneca Plc Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Novartis AG Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.14.3 Novartis AG Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Bristol-Myers Squibb Company Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.15.3 Bristol-Myers Squibb Company Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Genentech Inc. Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.16.3 Genentech Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Takeda Pharmaceutical Company Limited Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Antiandrogen Monotherapy Product Profiles, Application and Specification
8.17.3 Takeda Pharmaceutical Company Limited Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Antiandrogen Monotherapy Market Analysis and Forecast by Type and Application
9.1 Global Antiandrogen Monotherapy Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Steroidal Market Revenue and Volume Forecast (2021-2026)
9.1.2 Nonsteroidal Market Revenue and Volume Forecast (2021-2026)
9.2 Global Antiandrogen Monotherapy Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Prostate Cancer Market Revenue and Volume Forecast (2021-2026)
9.2.2 Benign Prostatic Hyperplasia Market Revenue and Volume Forecast (2021-2026)
9.2.3 Hirsutism Market Revenue and Volume Forecast (2021-2026)
9.2.4 Hyperandrogenism Market Revenue and Volume Forecast (2021-2026)
9.2.5 Others Market Revenue and Volume Forecast (2021-2026)
10 Antiandrogen Monotherapy Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Antiandrogen Monotherapy Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
